Alan Bilsland

6.8k total citations
37 papers, 988 citations indexed

About

Alan Bilsland is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Alan Bilsland has authored 37 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Physiology and 6 papers in Genetics. Recurrent topics in Alan Bilsland's work include Telomeres, Telomerase, and Senescence (18 papers), RNA Interference and Gene Delivery (10 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Alan Bilsland is often cited by papers focused on Telomeres, Telomerase, and Senescence (18 papers), RNA Interference and Gene Delivery (10 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Alan Bilsland collaborates with scholars based in United Kingdom, United States and Italy. Alan Bilsland's co-authors include W. Nicol Keith, Jiangqin Zhao, T.R. Jeffry Evans, Claire J. Cairney, Marta Bon, Rosalind Glasspool, Justin Bower, Stacey F. Hoare, Jane A. Plumb and Richard J. Knox and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Alan Bilsland

37 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Bilsland United Kingdom 21 698 387 190 138 120 37 988
A. M. Burger United States 15 799 1.1× 176 0.5× 73 0.4× 111 0.8× 368 3.1× 30 1.2k
Huawei Qiu United States 17 727 1.0× 202 0.5× 61 0.3× 90 0.7× 159 1.3× 39 1.1k
Guikai Wu United States 18 825 1.2× 211 0.5× 53 0.3× 25 0.2× 245 2.0× 22 1.2k
Ekaterina Bassett United States 14 801 1.1× 268 0.7× 74 0.4× 88 0.6× 510 4.3× 15 1.2k
R A Rifkind United States 14 651 0.9× 157 0.4× 79 0.4× 30 0.2× 221 1.8× 16 917
Yuebo Gan United States 16 410 0.6× 102 0.3× 40 0.2× 40 0.3× 187 1.6× 20 686
Johannes Ottl Switzerland 19 731 1.0× 27 0.1× 67 0.4× 54 0.4× 192 1.6× 32 1.1k
Dawid Walerych Poland 14 1.0k 1.5× 42 0.1× 50 0.3× 76 0.6× 506 4.2× 20 1.3k
Sanjeev Das India 19 668 1.0× 61 0.2× 59 0.3× 61 0.4× 415 3.5× 36 1.1k
MV Blagosklonny United States 9 547 0.8× 25 0.1× 54 0.3× 64 0.5× 185 1.5× 9 773

Countries citing papers authored by Alan Bilsland

Since Specialization
Citations

This map shows the geographic impact of Alan Bilsland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Bilsland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Bilsland more than expected).

Fields of papers citing papers by Alan Bilsland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Bilsland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Bilsland. The network helps show where Alan Bilsland may publish in the future.

Co-authorship network of co-authors of Alan Bilsland

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Bilsland. A scholar is included among the top collaborators of Alan Bilsland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Bilsland. Alan Bilsland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilsland, Alan, et al.. (2023). SFRP1 Expression is Inversely Associated With Metastasis Formation in Canine Mammary Tumours. Journal of Mammary Gland Biology and Neoplasia. 28(1). 15–15. 1 indexed citations
2.
Evans, T.R. Jeffry, Martin Eatock, Liz-Anne Lewsley, et al.. (2020). A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC).. Journal of Clinical Oncology. 38(4_suppl). 709–709. 4 indexed citations
3.
Bilsland, Alan, Yu Liu, A.P. Turnbull, et al.. (2019). A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length Regulation. Neoplasia. 21(9). 893–907. 4 indexed citations
4.
Bilsland, Alan, et al.. (2018). An Exploratory Study on the Use of Game-based Learning Using Microsoft Kinect to Teach Oncology Phase I Clinical Trial Designs. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
5.
Cairney, Claire J., Alan Bilsland, Sharon Burns, et al.. (2017). A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds. PLoS Genetics. 13(8). e1006942–e1006942. 10 indexed citations
6.
Ali, Asif, Sarah Bell, Alan Bilsland, et al.. (2015). 47P Investigating various thresholds as immunohistochemistry cut-offs for observer agreement. Annals of Oncology. 26. ix8–ix8. 8 indexed citations
7.
Bilsland, Alan, Angelo Pugliese, Yu Liu, et al.. (2015). Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks. Neoplasia. 17(9). 704–715. 15 indexed citations
8.
Bilsland, Alan, et al.. (2013). MicroRNA and Senescence: The Senectome, Integration and Distributed Control. Critical Reviews™ in Oncogenesis. 18(4). 373–390. 25 indexed citations
9.
Cairney, Claire J., Alan Bilsland, T.R. Jeffry Evans, et al.. (2012). Cancer cell senescence: a new frontier in drug development. Drug Discovery Today. 17(5-6). 269–276. 44 indexed citations
10.
Stolzenburg, Sabine, Alan Bilsland, W. Nicol Keith, & Marianne G. Rots. (2010). Modulation of Gene Expression Using Zinc Finger-Based Artificial Transcription Factors. Methods in molecular biology. 649. 117–132. 10 indexed citations
11.
Bilsland, Alan, Stacey F. Hoare, Sharon Burns, et al.. (2010). TCEAL7 Inhibition of c-Myc Activity in Alternative Lengthening of Telomeres Regulates hTERT Expression. Neoplasia. 12(5). 405–IN6. 22 indexed citations
12.
Bilsland, Alan, Stacey F. Hoare, Katrina H. Stevenson, et al.. (2009). Dynamic Telomerase Gene Suppression via Network Effects of GSK3 Inhibition. PLoS ONE. 4(7). e6459–e6459. 29 indexed citations
13.
Cairney, Claire J., Nedime Serakıncı, Maria Grazia Daidone, et al.. (2009). A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene. 28(43). 3765–3774. 51 indexed citations
14.
Bilsland, Alan, et al.. (2005). Properties of a Telomerase-Specific Cre/Lox Switch for Transcriptionally Targeted Cancer Gene Therapy. Neoplasia. 7(11). 1020–1029. 13 indexed citations
15.
Ashcroft, Margaret, et al.. (2005). Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene. 25(1). 61–69. 74 indexed citations
16.
Keith, W. Nicol, Tom Vulliamy, Jiangqin Zhao, et al.. (2004). A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. PubMed. 4(1). 3–3. 28 indexed citations
17.
Bilsland, Alan, Fiona McGregor, T.R. Jeffry Evans, et al.. (2003). Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase. Oncogene. 22(3). 370–380. 64 indexed citations
18.
Keith, W. Nicol, Alan Bilsland, T.R. Jeffry Evans, & Rosalind Glasspool. (2002). Telomerase-directed molecular therapeutics. Expert Reviews in Molecular Medicine. 4(10). 1–25. 35 indexed citations
19.
Plumb, Jane A., Alan Bilsland, Jiangqin Zhao, et al.. (2001). Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene. 20(53). 7797–7803. 82 indexed citations
20.
Zhao, Jiangqin, Rosalind Glasspool, Stacey F. Hoare, et al.. (2000). Activation of Telomerase RNA Gene Promoter Activity by NF-Y, Sp1, and the Retinoblastoma Protein and Repression by Sp3. Neoplasia. 2(6). 531–539. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Burger Breakdown of academic impact, for papers by Huawei Qiu Breakdown of academic impact, for papers by Guikai Wu Breakdown of academic impact, for papers by Ekaterina Bassett Breakdown of academic impact, for papers by R A Rifkind Breakdown of academic impact, for papers by Yuebo Gan Breakdown of academic impact, for papers by Johannes Ottl Breakdown of academic impact, for papers by Dawid Walerych Breakdown of academic impact, for papers by Sanjeev Das Breakdown of academic impact, for papers by MV Blagosklonny
Rankless by CCL
2026